Introduction
• High frequencies of melanoma antigen-specific CD8 + T cells induced by vaccination or adoptive transfer do not always translate into tumor regression • This observation has prompted investigation into the tumor microenvironment to identify potential factors that positively or negatively regulate the effector phase of an anti-tumor immune response • One approach has been to characterize gene expression profiles from metastatic melanoma tumors (core biopsies or resected specimens)
Methods
• RNA was extracted from tumor biopsies of patients with metastatic melanoma (n=33) as well as from melanoma cell lines (n=5) and primary melanocyte cell lines (n=3) • Gene array analysis was performed (Affymetrix chip U133A) • Data was analyzed using dChip software, filtering for genes present in >10% of samples and with variation of std. dev./mean between 1 and 10. 735 genes with variable gene expression were identified.
• Genes and samples were clustered using hierarchical cluster analysis.
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